Found 20 matching trials
Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis EARLY_PHASE1 Radiation-induced cystitis is a condition commonly seen in patients who hav...
Show More Location
Ramathibodi Hospital
Learn More & Join Trial
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder PHASE2 The study is intended to test efficacy, safety and tolerability of two dose...
Show More Learn More & Join Trial
Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study PHASE4 To evaluate the impact of combined therapy on the heart rate variability, c...
Show More Location
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Learn More & Join Trial
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder PHASE4 Overactive bladder is more prevalent among the Sjogren syndrome's populatio...
Show More Location
China Medical University Hospital
Learn More & Join Trial
Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder PHASE3 The study is intended to test efficacy, safety and tolerability of two dose...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Incontinence Without Memory Problems PHASE4 An 8-week randomized, controlled, pilot clinical trial of Mirabegron compar...
Show More Location
University of California, San Francisco
Learn More & Join Trial
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) N/A A study to identify factors that are associated with improved effectiveness...
Show More Learn More & Join Trial
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder PHASE3 The study is intended to test the safety, tolerability, efficacy of two dos...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of YM178 in Subjects With Symptoms of Overactive Bladder PHASE3 This study is to assess the efficacy and safety of YM178 in patients with s...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Antimuscarinic Treatment on Premature Ejaculation Severity in Men With Overactive Bladder: a Prospective Comparison With Mirabegron N/A Overactive bladder (OAB) is a condition characterized by involuntary bladde...
Show More Location
Başakşehir Çam and Sakura City Hospital, Department of Urology
Learn More & Join Trial